CMS has indicated it is collecting utilization data during the program period to inform longer-term policy decisions
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
Its key actions include: Stimulating glucose-dependent insulin secretion from pancreatic beta cells Inhibiting glucagon secretion , which otherwise raises blood sugar Slowing gastric emptying , which delays the absorption of glucose Promoting satiety via central nervous system signalling The role of GLP-1 was uncovered in the 1980s during research into the incretin effect the observation that oral glucose stimulated more insulin than intravenous glucose
Talk to your provider about this
So, taking it this way helps protect the medication from digestion and ensures it reaches your bloodstream, where it can then travel to the GLP-1 receptors in the brain and perform its actions
doi:10.3233/JAD-220180 Ning P, Luo A, Mu X, Xu Y, Li T